The growing adoption of BCI technology is attributable to its rising awareness in treating a wide range of brain disorders. The growing incidences of brain disorders, stroke, depression, and Parkinson ...
Precision Neuroscience Recognized for Innovation and Responsible Technology with Two Industry Awards
Precision Neuroscience Corporation (Precision™) a leader in brain–computer interface (BCI) technology, has been named to Inc. Magazine’s 2025 Best in Business list in the Best in Innovation category.
US brain-computer-interface startup Paradromics is quickly establishing itself as a major player in the neural-device space, ...
Paradromics announced that it received FDA investigational device exemption (IDE) to begin a study of its brain-computer ...
FDA approves first human trial for Paradromics' brain-computer interface that could restore speech for paralyzed patients ...
As brain-computer interface (BCI) and neurotechnology continue to develop, there is growing interest in these emerging scientific areas, from both academic and business circles. BCI has various ...
Neurotechnology company Paradromics will test its device in a trial aimed at safely restoring speech for people with severe motor impairments.
Disability unearths creativity, former BCI user Ian Burkhart said in an interview with The Verge. People with disabilities ...
A recent scientific preprint published by Paradromics reported that the Connexus implant – a tiny device that is implanted ...
NEW YORK--(BUSINESS WIRE)--Synchron, the brain-computer interface (BCI) company developing endovascular technology to restore functionality in patients with motor impairment, today announced the ...
The distress in the psychedelic space contributed to the Company's challenges. The inability of the Company to undertake certain corporate actions (name and symbol change etc.) due to regulatory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results